What is Honeywell International, Inc.'s earnings per share (EPS)?

Honeywell International, Inc. (HON) reported diluted earnings per share of $7.36 for fiscal year 2025. This represents a -15.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Honeywell International, Inc. (HON) Financials

HON

Trailing 12 months to June 30, 2026

Revenue $38.1B +5.0% YoY

Net Income $8.2B +43.7% YoY

EPS (Diluted) $7.36 FY2025 annual

Free Cash Flow $4.0B -25.7% YoY

Market Cap $65.7B as of Oct 13, 2026

Price / Sales 1.7x on $38.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 8.0x on $8.2B net income, trailing 12 months to June 30, 2026

Price / Book 3.5x on $18.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 23, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the HON SEC filings page.

Honeywell International, Inc. (HON) reported $38.1B in revenue over the twelve months to Jun 30, 2026, up 5.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI HON FY2025 2026-10-04

Honeywell is growing sales while higher financing costs and heavier leverage make 2025 earnings lag its cash generation.

From FY2024 to FY2025, operating cash flow rose from $6.1B to $6.4B even as net income fell from $5.7B to $4.7B, showing that the underlying cash-producing operation held up better than the reported bottom line. Interest expense also increased from $1.0B to $1.3B, helping explain why accounting profit weakened without a matching deterioration in cash generation.

Sales growth did not translate proportionately into gross profit: revenue reached $37.4B in FY2025, while gross margin narrowed to 36.9% from 38.5% a year earlier. The pattern points to cost or mix pressure, rather than simple volume-driven expansion, and operating margin slipped to 21.7%.

The balance sheet became more leveraged even though short-term coverage stayed broadly stable. Debt-to-equity rose from 1.4x to 2.0x as equity contracted, while the current ratio remained near 1.3x; this indicates a shift in long-term financing structure more than a sudden change in day-to-day liquidity.

Financial Health Signals

Financial Health Score 63/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Honeywell International, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Honeywell International, Inc. has an operating margin of 21.7%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 92/100, reflecting efficient cost management and pricing power. This is down from 22.1% the prior year.

Growth

Honeywell International, Inc.'s revenue grew 7.8% year-over-year to $37.4B, a solid pace of expansion. This earns a growth score of 55/100.

Leverage

Honeywell International, Inc. has a moderate D/E ratio of 1.95. This balance of debt and equity financing earns a leverage score of 37/100.

Liquidity

Honeywell International, Inc.'s current ratio of 1.30 indicates adequate short-term liquidity, earning a score of 33/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Honeywell International, Inc. converts 14.5% of revenue into free cash flow ($5.4B). This strong cash generation earns a score of 77/100.

Returns

Honeywell International, Inc. earns a strong 34.0% return on equity (ROE), meaning it generates $34 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is up from 30.6% the prior year.

Altman Z-Score Grey Zone

2.61

Honeywell International, Inc. scores 2.61, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Honeywell International, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

1.36x

For every $1 of reported earnings, Honeywell International, Inc. generates $1.36 in operating cash flow ($6.4B OCF vs $4.7B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

6.05x

Honeywell International, Inc. earns $6.05 in operating income for every $1 of interest expense ($8.1B vs $1.3B). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.7B

YoY+4.3%

QoQ+6.3%

5Y CAGR+2.0%

10Y CAGR-0.3%

Honeywell International, Inc. generated $9.7B in revenue in Q2 2026. This represents an increase of 4.3% from the same quarter a year earlier. Against the prior quarter it is up 6.3%.

EBITDA

$2.6B

YoY+3.1%

QoQ+2.7%

Honeywell International, Inc.'s EBITDA was $2.6B in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 3.1% from the same quarter a year earlier. Against the prior quarter it is up 2.7%.

Net Income

$5.7B

YoY+261.9%

QoQ+592.1%

5Y CAGR+31.8%

10Y CAGR+15.7%

Honeywell International, Inc. reported $5.7B in net income in Q2 2026. This represents an increase of 261.9% from the same quarter a year earlier. Against the prior quarter it is up 592.1%.

EPS (Diluted)

$17.83

5Y CAGR+54.3%

10Y CAGR+26.5%

Honeywell International, Inc. earned $17.83 per diluted share (EPS) in Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$961.0M

YoY-12.1%

QoQ+210.1%

5Y CAGR-2.5%

10Y CAGR-3.0%

Honeywell International, Inc. generated $961.0M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 12.1% from the same quarter a year earlier. Against the prior quarter it is up 210.1%.

Cash & Debt

$8.8B

YoY-15.4%

QoQ-26.9%

5Y CAGR-5.2%

10Y CAGR+5.7%

Honeywell International, Inc. held $8.8B in cash against $26.2B in long-term debt as of Q2 2026.

Dividends Per Share

$2.38

5Y CAGR+20.7%

10Y CAGR+14.9%

Honeywell International, Inc. paid $2.38 per share in dividends in Q2 2026.

Shares Outstanding

317M

5Y CAGR-14.4%

10Y CAGR-8.4%

Honeywell International, Inc. had 317M shares outstanding in Q2 2026.

Margins & Returns

Gross Margin

37.6%

YoY-1.7pp

QoQ-1.1pp

5Y change+5.7pp

10Y change+5.9pp

Honeywell International, Inc.'s gross margin was 37.6% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.

Operating Margin

23.1%

YoY+0.2pp

QoQ-0.2pp

Honeywell International, Inc.'s operating margin was 23.1% in Q2 2026, reflecting core business profitability. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.2 percentage points.

Net Margin

58.5%

YoY+41.6pp

QoQ+49.5pp

5Y change+42.2pp

10Y change+45.3pp

Honeywell International, Inc.'s net profit margin was 58.5% in Q2 2026, showing the share of revenue converted to profit. This is up 41.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 49.5 percentage points.

Return on Equity

30.6%

YoY+20.9pp

QoQ+24.6pp

5Y change+22.7pp

10Y change+23.6pp

Honeywell International, Inc.'s ROE was 30.6% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 20.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 24.6 percentage points.

Capital Allocation

R&D Spending

$524.0M

YoY+14.2%

QoQ+6.5%

Honeywell International, Inc. invested $524.0M in research and development in Q2 2026. This represents an increase of 14.2% from the same quarter a year earlier. Against the prior quarter it is up 6.5%.

Share Buybacks

YoY-100.0%

QoQ-100.0%

Honeywell International, Inc. repurchased no shares in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Capital Expenditures

$315.0M

YoY+39.4%

QoQ+41.3%

5Y CAGR+11.2%

10Y CAGR+1.1%

Honeywell International, Inc. invested $315.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 39.4% from the same quarter a year earlier. Against the prior quarter it is up 41.3%.

HON Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HON quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$38.1B	$37.4B+7.8%	$34.7B+5.2%	$33.0B-6.9%	$35.5B+3.1%	$34.4B+5.4%	$32.6B-11.1%	$36.7B-12.2%	$41.8B+3.1%	$40.5B+3.1%	$39.3B+1.9%	$38.6B-4.3%	$40.3B+3.2%	$39.1B+3.7%	$37.7B+3.1%	$36.5B
Cost of Revenue	N/A	$23.6B+10.5%	$21.4B+3.5%	$20.6B-7.7%	$22.3B+1.3%	$22.1B-0.5%	$22.2B-8.9%	$24.3B-16.2%	$29.0B+3.2%	$28.1B+1.7%	$27.7B+3.5%	$26.7B-7.6%	$29.0B+2.1%	$28.4B+0.3%	$28.3B-0.9%	$28.6B
Gross Profit	$13.9B	$13.8B+3.5%	$13.4B+8.0%	$12.4B-5.7%	$13.1B+6.4%	$12.3B+17.8%	$10.5B-15.4%	$12.4B-3.0%	$12.8B+3.0%	$12.4B+2.0%	$12.2B+2.7%	$11.8B+4.3%	$11.3B+6.2%	$10.7B+14.0%	$9.4B+17.6%	$8.0B
R&D Expenses	N/A	$1.8B+24.6%	$1.5B+5.7%	$1.4B-7.0%	$1.5B+10.9%	$1.3B-0.1%	$1.3B-14.3%	$1.6B-14.0%	$1.8B-1.4%	$1.8B-1.6%	$1.9B+0.4%	$1.9B-1.9%	$1.9B+4.9%	$1.8B-2.3%	$1.8B+2.7%	$1.8B
SG&A Expenses	N/A	$5.5B+4.1%	$5.2B+7.1%	$4.9B-6.3%	$5.2B+8.7%	$4.8B+0.5%	$4.8B-13.5%	$5.5B-8.8%	$6.1B-0.6%	$6.1B+9.2%	$5.6B+11.3%	$5.0B-9.3%	$5.5B+6.3%	$5.2B-0.5%	$5.2B-3.4%	$5.4B
Operating Income	N/A	$8.1B+6.0%	$7.7B+1.4%	$7.6B-5.7%	$8.0B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA	N/A	$9.5B+7.9%	$8.8B+3.0%	$8.6B-7.1%	$9.2B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$1.3B+28.2%	$1.0B+39.9%	$749.0M+80.9%	$414.0M+20.7%	$343.0M-4.5%	$359.0M+0.6%	$357.0M-2.7%	$367.0M+16.1%	$316.0M-6.5%	$338.0M+9.0%	$310.0M-2.5%	$318.0M-2.8%	$327.0M-6.8%	$351.0M-6.6%	$376.0M
Income Tax	N/A	$1.0B-19.3%	$1.2B-1.0%	$1.3B-10.6%	$1.4B-13.1%	$1.6B+41.7%	$1.1B-13.7%	$1.3B+101.7%	$659.0M-87.7%	$5.4B+234.5%	$1.6B-7.8%	$1.7B+16.8%	$1.5B+2.7%	$1.4B+53.6%	$944.0M+126.4%	$417.0M
Net Income	$8.2B	$4.7B-17.1%	$5.7B+0.8%	$5.7B+13.9%	$5.0B-10.4%	$5.5B+16.0%	$4.8B-22.2%	$6.1B-9.2%	$6.8B+337.9%	$1.5B-67.9%	$4.8B+0.9%	$4.8B+12.5%	$4.2B+8.0%	$3.9B+34.1%	$2.9B+41.6%	$2.1B
EPS (Basic)	N/A	$7.40-15.5%	$8.76+2.7%	$8.53+16.4%	$7.33-8.5%	$8.01+18.0%	$6.79-20.3%	$8.52-6.4%	$9.10+348.3%	$2.03-67.8%	$6.30+3.1%	$6.11+13.1%	$5.40+8.2%	$4.99+33.4%	$3.74+41.1%	$2.65
EPS (Diluted)	—	$7.36-15.5%	$8.71+2.8%	$8.47+16.5%	$7.27-8.1%	$7.91+17.7%	$6.72-20.1%	$8.41-6.3%	$8.98+349.0%	$2.00-67.8%	$6.21+2.8%	$6.04+13.3%	$5.33+8.3%	$4.92+33.3%	$3.69+41.4%	$2.61
Diluted Shares (Avg)	N/A	643M-1.9%	655M-1.9%	668M-2.2%	683M-2.5%	700M-1.5%	711M-2.6%	730M-3.0%	753M-2.5%	772M-0.4%	775M-1.8%	789M-0.7%	795M-0.3%	797M+0.7%	792M0.0%	792M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$9.7B+4.3%	$9.1B+2.4%	$9.8B+6.4%	$9.4B+7.0%	$9.3B+8.7%	$8.9B+9.4%	$9.2B+58.4%	$8.8B-4.3%
Cost of Revenue	$6.1B+7.2%	$5.6B+2.6%	N/A	$6.9B+14.8%	$5.7B-3.4%	$5.5B-2.1%	N/A	$6.0B+5.4%
Gross Profit	$3.7B-0.3%	$3.5B+2.2%	$3.5B+3.1%	$3.2B-5.4%	$3.7B+9.3%	$3.5B+7.4%	$3.4B+73.1%	$3.4B-3.5%
R&D Expenses	$524.0M+14.2%	$492.0M+18.3%	N/A	$497.0M+35.1%	$459.0M+20.2%	$416.0M+15.6%	N/A	$368.0M+1.1%
SG&A Expenses	$1.3B-1.3%	$1.3B0.0%	N/A	$1.3B-7.3%	$1.4B+0.1%	$1.3B+0.6%	N/A	$1.4B+11.7%
Operating Income	$2.2B+5.3%	$2.1B+6.3%	N/A	$2.4B+4.8%	$2.1B-3.2%	$2.0B-4.4%	N/A	$2.3B+5.8%
EBITDA	$2.6B+3.1%	$2.5B+6.8%	N/A	$2.8B+5.7%	$2.5B-1.3%	$2.3B-2.4%	N/A	$2.7B+9.5%
Interest Expense	$363.0M+10.3%	$356.0M+24.9%	N/A	$354.0M+19.2%	$329.0M+31.6%	$285.0M+29.5%	N/A	$297.0M+44.2%
Income Tax	$1.6B+546.7%	$91.0M-75.3%	N/A	$363.0M-11.2%	$244.0M-41.1%	$369.0M-6.8%	N/A	$409.0M-9.5%
Net Income	$5.7B+261.9%	$821.0M-43.3%	-$115.0M-108.9%	$1.8B+29.2%	$1.6B+1.6%	$1.4B-0.9%	$1.3B+1.7%	$1.4B-6.7%
EPS (Basic)	$17.92+264.2%	$1.29-42.4%	-$0.18-109.1%	$2.87+32.3%	$4.92+107.6%	$2.240.0%	$1.98+3.1%	$2.17-5.2%
EPS (Diluted)	$17.83	$1.29-41.9%	-$0.18-109.2%	$2.86+32.4%	$4.90	$2.22-0.4%	$1.96+2.6%	$2.16-4.8%
Diluted Shares (Avg)	319M	638M-2.0%	N/A	639M-2.3%	321M	652M-0.7%	N/A	654M-1.9%

HON Balance Sheet

HON quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$73.7B-2.0%	$75.2B+22.2%	$61.5B-1.2%	$62.3B-3.4%	$64.5B-0.2%	$64.6B+10.1%	$58.7B+1.6%	$57.8B-2.9%	$59.5B+9.0%	$54.6B+10.6%	$49.3B+8.5%	$45.5B0.0%	$45.4B+8.6%	$41.9B+5.1%	$39.8B
Current Assets	$30.4B+8.9%	$27.9B+18.7%	$23.5B-5.9%	$25.0B-1.5%	$25.4B-9.9%	$28.2B+15.9%	$24.3B-0.2%	$24.4B-6.3%	$26.0B+12.8%	$23.1B+15.0%	$20.1B-9.6%	$22.2B+4.9%	$21.2B+20.3%	$17.6B+9.1%	$16.1B
Cash & Equivalents	$12.5B+26.1%	$9.9B+25.0%	$7.9B-17.7%	$9.6B-12.2%	$11.0B-23.2%	$14.3B+57.4%	$9.1B-2.4%	$9.3B+31.6%	$7.1B-10.0%	$7.8B+43.8%	$5.5B-21.6%	$7.0B+8.4%	$6.4B+38.6%	$4.6B+25.3%	$3.7B
Short-Term Investments	$443.0M+14.8%	$386.0M+127.1%	$170.0M-64.8%	$483.0M-14.4%	$564.0M-40.3%	$945.0M-29.9%	$1.3B-16.9%	$1.6B-56.8%	$3.8B+147.2%	$1.5B	$0	$0	$0	$0	$0
Inventory	$6.2B+4.7%	$5.9B-4.8%	$6.2B+11.6%	$5.5B+7.8%	$5.1B+14.5%	$4.5B+1.5%	$4.4B+2.2%	$4.3B-6.2%	$4.6B+5.7%	$4.4B-1.2%	$4.4B+0.3%	$4.4B+2.6%	$4.3B+1.4%	$4.2B-0.7%	$4.3B
Accounts Receivable	$7.6B+5.2%	$7.2B-3.8%	$7.5B+1.2%	$7.4B+8.9%	$6.8B0.0%	$6.8B-8.9%	$7.5B-0.2%	$7.5B-15.3%	$8.9B+8.4%	$8.2B	N/A	N/A	N/A	N/A	$7.2B
Long-Term Investments	$1.2B	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$143.0M-66.3%	$424.0M+17.1%	$362.0M
Goodwill	$21.1B+0.3%	$21.0B+21.9%	$17.2B-1.5%	$17.5B-1.5%	$17.8B+10.6%	$16.1B+3.2%	$15.6B+0.1%	$15.5B-14.9%	$18.3B+3.2%	$17.7B+11.4%	$15.9B+24.3%	$12.8B-2.0%	$13.0B+5.0%	$12.4B+4.8%	$11.9B
Total Liabilities	$59.8B+5.7%	$56.6B+23.9%	$45.7B+0.2%	$45.6B-0.7%	$45.9B-2.4%	$47.0B+17.1%	$40.2B+1.5%	$39.6B-7.9%	$43.0B+22.1%	$35.2B+13.4%	$31.0B+11.7%	$27.8B-0.6%	$28.0B-3.2%	$28.9B-0.4%	$29.0B
Current Liabilities	$23.4B+10.2%	$21.3B+14.7%	$18.5B-7.0%	$19.9B+2.2%	$19.5B+1.6%	$19.2B+6.1%	$18.1B-4.4%	$18.9B+0.3%	$18.9B+15.5%	$16.3B-11.1%	$18.4B+24.4%	$14.8B+4.2%	$14.2B+8.7%	$13.0B+6.3%	$12.3B
Non-Current Liabilities	$36.4B+3.0%	$35.3B+30.2%	$27.1B+5.8%	$25.6B-2.9%	$26.4B-5.2%	$27.8B+26.0%	$22.1B+6.9%	$20.7B-14.3%	$24.1B+27.8%	$18.9B+49.0%	$12.7B-2.8%	$13.0B-5.6%	$13.8B-12.9%	$15.8B-5.3%	$16.7B
Long-Term Debt	$27.1B+6.7%	$25.4B+53.6%	$16.6B+9.5%	$15.1B+6.1%	$14.3B-12.8%	$16.3B+47.1%	$11.1B+13.9%	$9.8B-22.4%	$12.6B+3.2%	$12.2B+119.3%	$5.6B-8.1%	$6.0B-11.1%	$6.8B+6.3%	$6.4B-7.1%	$6.9B
Total Equity	$13.9B-25.3%	$18.6B+17.4%	$15.9B-5.0%	$16.7B-10.1%	$18.6B+5.8%	$17.5B-5.1%	$18.5B+1.7%	$18.2B+10.2%	$16.5B-14.8%	$19.4B+5.9%	$18.3B+3.5%	$17.7B+1.1%	$17.5B+34.6%	$13.0B+20.1%	$10.8B
Retained Earnings	$51.0B+0.3%	$50.8B+6.0%	$48.0B+6.4%	$45.1B+5.3%	$42.8B+7.3%	$39.9B+5.9%	$37.7B+10.9%	$34.0B+23.6%	$27.5B-4.3%	$28.7B+9.8%	$26.1B+13.1%	$23.1B+13.4%	$20.4B+14.5%	$17.8B+10.7%	$16.1B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$77.3B-1.4%	$74.0B-1.6%	$73.7B-2.0%	$80.9B+10.1%	$78.4B+13.1%	$75.2B+14.6%	$75.2B+22.2%	$73.5B+19.9%
Current Assets	$28.1B+0.4%	$30.6B+10.7%	$30.4B+8.9%	$30.7B+9.2%	$28.0B+10.2%	$27.6B+0.8%	$27.9B+18.7%	$28.2B+20.8%
Cash & Equivalents	$8.8B-15.4%	$12.0B+24.0%	$12.5B+26.1%	$12.9B+21.5%	$10.3B+8.1%	$9.7B-17.9%	$9.9B+25.0%	$10.6B+37.0%
Short-Term Investments	$445.0M+35.7%	$413.0M+2.7%	$443.0M+14.8%	$429.0M+56.0%	$328.0M+42.0%	$402.0M+61.4%	$386.0M+127.1%	$275.0M+67.7%
Inventory	$6.4B-8.7%	$6.4B-3.7%	$6.2B+4.7%	$7.1B+12.3%	$7.0B+10.9%	$6.6B+4.6%	$5.9B-4.8%	$6.3B+5.6%
Accounts Receivable	$8.3B-5.5%	$8.1B-2.3%	$7.6B+5.2%	$8.9B+13.2%	$8.8B+13.7%	$8.3B+10.4%	$7.2B-3.8%	$7.9B+0.7%
Long-Term Investments	$1.2B	$0	$1.2B	$0	$0	$0	$0	$0
Goodwill	$20.0B-16.1%	$21.1B-4.3%	$21.1B+0.3%	$23.7B+11.5%	$23.8B+14.3%	$22.0B+22.4%	$21.0B+21.9%	$21.3B+19.5%
Total Liabilities	$58.8B-5.6%	$60.4B+4.6%	$59.8B+5.7%	$64.1B+14.4%	$62.3B+19.0%	$57.8B+17.4%	$56.6B+23.9%	$56.1B+27.3%
Current Liabilities	$23.2B+7.3%	$22.1B+0.1%	$23.4B+10.2%	$22.6B+15.9%	$21.6B+2.7%	$22.1B+33.9%	$21.3B+14.7%	$19.5B+13.4%
Non-Current Liabilities	$35.6B-12.5%	$38.3B+7.4%	$36.4B+3.0%	$41.5B+13.5%	$40.7B+29.9%	$35.7B+9.1%	$35.3B+30.2%	$36.6B+36.2%
Long-Term Debt	$26.2B-13.1%	$29.0B+12.7%	$27.1B+6.7%	$30.1B+16.0%	$30.2B+44.6%	$25.7B+16.1%	$25.4B+53.6%	$25.9B+55.5%
Total Equity	$18.5B+15.2%	$13.6B-22.2%	$13.9B-25.3%	$16.8B-3.6%	$16.1B-5.0%	$17.5B+6.1%	$18.6B+17.4%	$17.4B+1.0%
Retained Earnings	$56.0B+6.8%	$51.0B-1.0%	$51.0B+0.3%	$53.5B+6.4%	$52.4B+5.7%	$51.5B+5.8%	$50.8B+6.0%	$50.3B+6.0%

HON Cash Flow Statement

HON quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$5.1B	$6.4B+5.1%	$6.1B+14.2%	$5.3B+1.3%	$5.3B-12.7%	$6.0B-2.7%	$6.2B-10.0%	$6.9B+7.2%	$6.4B+7.8%	$6.0B+8.5%	$5.5B-0.4%	$5.5B+8.6%	$5.1B+17.2%	$4.3B+23.3%	$3.5B+24.1%	$2.8B
Depreciation & Amortization	N/A	$1.4B+20.4%	$1.2B+14.8%	$1.0B-16.6%	$1.2B+5.8%	$1.1B+13.5%	$1.0B-7.8%	$1.1B-2.5%	$1.1B+0.1%	$1.1B+8.3%	$1.0B+16.6%	$883.0M-4.4%	$924.0M-6.6%	$989.0M+6.8%	$926.0M-2.3%	$948.0M
Stock-Based Compensation	N/A	$196.0M+3.7%	$189.0M-4.1%	$197.0M+4.8%	$188.0M-13.4%	$217.0M+29.2%	$168.0M+9.8%	$153.0M-12.6%	$175.0M-0.6%	$176.0M-4.3%	$184.0M+5.1%	$175.0M-6.4%	$187.0M+10.0%	$170.0M0.0%	$170.0M+1.2%	$168.0M
Capital Expenditures	$1.1B	$986.0M+13.2%	$871.0M+17.5%	$741.0M-3.3%	$766.0M-14.4%	$895.0M-1.2%	$906.0M+8.0%	$839.0M+1.3%	$828.0M-19.7%	$1.0B-5.8%	$1.1B+2.1%	$1.1B-1.9%	$1.1B+15.5%	$947.0M+7.1%	$884.0M+11.9%	$790.0M
Free Cash Flow	$4.0B	$5.4B+3.8%	$5.2B+13.6%	$4.6B+2.0%	$4.5B-12.3%	$5.1B-3.0%	$5.3B-12.5%	$6.1B+8.1%	$5.6B+13.6%	$4.9B+12.1%	$4.4B-1.0%	$4.4B+11.5%	$4.0B+17.7%	$3.4B+28.7%	$2.6B+28.9%	$2.0B
Investing Cash Flow	-$1.9B	-$2.7B+73.3%	-$10.2B-685.5%	-$1.3B-1290.3%	-$93.0M+91.2%	-$1.1B-7.5%	-$987.0M-85.2%	-$533.0M-151.9%	$1.0B+128.7%	-$3.6B-6.9%	-$3.3B+48.7%	-$6.5B	N/A	N/A	-$1.4B-133.7%	-$611.0M
Financing Cash Flow	-$4.8B	-$2.0B-128.6%	$6.8B+218.7%	-$5.8B+9.0%	-$6.3B+23.3%	-$8.3B-10090.1%	-$81.0M+98.8%	-$6.6B-31.2%	-$5.0B-43.1%	-$3.5B-1116.2%	$346.0M+835.1%	$37.0M	N/A	N/A	-$1.2B-8.3%	-$1.1B
Dividends Paid	$3.1B	$3.0B+2.5%	$2.9B+1.6%	$2.9B+5.0%	$2.7B+3.5%	$2.6B+1.3%	$2.6B+6.1%	$2.4B+7.5%	$2.3B+7.2%	$2.1B+10.7%	$1.9B+11.0%	$1.7B+14.3%	$1.5B+11.6%	$1.4B+11.7%	$1.2B+11.0%	$1.1B
Share Buybacks	$1.2B	$3.8B+129.8%	$1.7B-55.5%	$3.7B-11.5%	$4.2B+24.3%	$3.4B-9.0%	$3.7B-15.6%	$4.4B+10.0%	$4.0B+38.5%	$2.9B+39.0%	$2.1B+10.4%	$1.9B+103.9%	$924.0M-13.9%	$1.1B+238.5%	$317.0M-70.8%	$1.1B

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$1.3B-3.3%	-$650.0M-208.9%	$1.2B-47.2%	$3.3B+64.6%	$1.3B-3.8%	$597.0M+33.3%	$2.3B-22.8%	$2.0B+10.4%
Depreciation & Amortization	$312.0M-10.3%	$357.0M+9.8%	$213.0M+8.7%	$397.0M+11.2%	$348.0M+12.6%	$325.0M+11.7%	$196.0M-33.6%	$357.0M+41.1%
Stock-Based Compensation	-$51.0M+7.3%	$57.0M-3.4%	N/A	-$36.0M+20.0%	-$55.0M0.0%	$59.0M+11.3%	N/A	-$45.0M
Capital Expenditures	$315.0M+39.4%	$223.0M+17.4%	$58.0M-42.0%	$512.0M+83.5%	$226.0M-12.7%	$190.0M-18.5%	$100.0M+51.5%	$279.0M+12.0%
Free Cash Flow	$961.0M-12.1%	-$873.0M-314.5%	$1.1B-47.5%	$2.8B+61.6%	$1.1B-1.7%	$407.0M+89.3%	$2.2B-24.5%	$1.7B+10.1%
Investing Cash Flow	-$929.0M+38.4%	-$119.0M+67.9%	-$343.0M+82.5%	-$488.0M+82.6%	-$1.5B+70.6%	-$371.0M-35.9%	-$2.0B-262.7%	-$2.8B-6115.6%
Financing Cash Flow	-$3.5B-562.8%	$267.0M+122.6%	-$1.3B-499.5%	-$219.0M-112.4%	$759.0M-52.6%	-$1.2B-131.9%	-$219.0M+90.6%	$1.8B+168.6%
Dividends Paid	$795.0M+6.4%	$781.0M+6.7%	$762.0M+2.8%	$735.0M+2.8%	$747.0M+0.5%	$732.0M+4.1%	$741.0M+4.2%	$715.0M-1.8%
Share Buybacks	$0-100.0%	$1.0B-47.4%	$100.0M-78.0%	$100.0M	$1.7B+221.7%	$1.9B+183.5%	$455.0M-70.2%	$0-100.0%

HON Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HON quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	36.9%-1.5pp	38.5%+1.0pp	37.5%+0.5pp	37.0%+1.1pp	35.9%+3.8pp	32.1%-1.6pp	33.7%+3.2pp	30.5%-0.1pp	30.6%-0.3pp	30.9%+0.3pp	30.7%+2.5pp	28.2%+0.8pp	27.4%+2.5pp	24.9%+3.1pp	21.8%
Operating Margin	21.7%-0.4pp	22.1%-0.8pp	22.9%+0.3pp	22.6%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	12.6%-3.8pp	16.4%-0.7pp	17.1%+3.1pp	14.0%-2.1pp	16.1%+1.5pp	14.6%-2.1pp	16.7%+0.6pp	16.2%+12.4pp	3.8%-8.4pp	12.2%-0.1pp	12.4%+1.8pp	10.5%+0.5pp	10.1%+2.3pp	7.8%+2.1pp	5.7%
Return on Equity	34.0%+3.4pp	30.6%-5.0pp	35.7%+5.9pp	29.7%-0.1pp	29.8%+2.6pp	27.2%-6.0pp	33.2%-4.0pp	37.2%+27.8pp	9.4%-15.5pp	24.8%-1.2pp	26.1%+2.1pp	24.0%+1.5pp	22.5%-0.1pp	22.6%+3.4pp	19.1%
Return on Assets	6.4%-1.2pp	7.6%-1.6pp	9.2%+1.2pp	8.0%-0.6pp	8.6%+1.2pp	7.4%-3.1pp	10.5%-1.2pp	11.7%+9.1pp	2.6%-6.2pp	8.8%-0.8pp	9.7%+0.3pp	9.3%+0.7pp	8.6%+1.7pp	7.0%+1.8pp	5.2%
Current Ratio	1.300.0x	1.310.0x	1.270.0x	1.250.0x	1.30-0.2x	1.47+0.1x	1.34+0.1x	1.29-0.1x	1.380.0x	1.41+0.3x	1.09-0.4x	1.500.0x	1.49+0.1x	1.350.0x	1.31
Debt-to-Equity	1.95+0.6x	1.37+0.3x	1.04+0.1x	0.91+0.1x	0.77-0.2x	0.93+0.3x	0.60+0.1x	0.54-0.2x	0.76+0.1x	0.63+0.3x	0.300.0x	0.340.0x	0.39-0.1x	0.49-0.1x	0.64
Asset Turnover	0.510.0x	0.46-0.1x	0.540.0x	0.570.0x	0.530.0x	0.51-0.1x	0.63-0.1x	0.720.0x	0.680.0x	0.72-0.1x	0.78-0.1x	0.890.0x	0.860.0x	0.900.0x	0.92
FCF Margin	14.5%-0.6pp	15.0%+1.1pp	13.9%+1.2pp	12.7%-2.2pp	14.9%-1.3pp	16.3%-0.3pp	16.5%+3.1pp	13.4%+1.2pp	12.2%+1.0pp	11.2%-0.3pp	11.5%+1.6pp	9.9%+1.2pp	8.7%+1.7pp	7.0%+1.4pp	5.6%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	37.6%-1.7pp	38.7%-0.1pp	35.6%-1.1pp	34.3%-4.5pp	39.3%+0.2pp	38.8%-0.7pp	36.7%+3.1pp	38.8%+0.3pp
Operating Margin	23.1%+0.2pp	23.3%+0.9pp	N/A	25.5%-0.5pp	22.8%-2.8pp	22.4%-3.2pp	N/A	26.0%+2.5pp
Net Margin	58.5%+41.6pp	9.0%-7.3pp	-1.2%-15.2pp	19.3%+3.3pp	16.8%-1.2pp	16.2%-1.7pp	14.0%-7.8pp	16.0%-0.4pp
Return on Equity	30.6%+20.9pp	6.0%-2.3pp	-0.8%-7.7pp	10.9%+2.8pp	9.8%+0.6pp	8.3%-0.6pp	6.9%-1.1pp	8.1%-0.7pp
Return on Assets	7.3%+5.3pp	1.1%-0.8pp	-0.2%-1.9pp	2.3%+0.3pp	2.0%-0.2pp	1.9%-0.3pp	1.7%-0.3pp	1.9%-0.6pp
Current Ratio	1.21-0.1x	1.39+0.1x	1.300.0x	1.36-0.1x	1.29+0.1x	1.25-0.4x	1.310.0x	1.44+0.1x
Debt-to-Equity	1.41-0.5x	2.13+0.7x	1.95+0.6x	1.79+0.3x	1.87+0.6x	1.47+0.1x	1.37+0.3x	1.49+0.5x
Asset Turnover	0.130.0x	0.120.0x	0.130.0x	0.120.0x	0.120.0x	0.120.0x	0.120.0x	0.120.0x
FCF Margin	9.9%-1.8pp	-9.6%-14.1pp	11.7%-12.0pp	29.4%+9.9pp	11.7%-1.3pp	4.6%+1.9pp	23.8%-26.1pp	19.5%+2.5pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Honeywell International, Inc. HON	FY2025	$37.4B	$4.7B	12.6%	$65.7B	63/100
3M Company MMM	FY2025	$24.9B	$3.3B	13.0%	$83.0B	46/100
Valmont Industries, Inc. VMI	FY2025	$4.1B	$350.3M	8.5%	$9.0B	58/100
Otter Tail Corp OTTR	FY2025	$1.3B	$275.9M	21.2%	$3.7B	60/100
Seaboard Corporation SEB	FY2025	$9.7B	$501.0M	5.1%	$3.8B	41/100
Brookfield Business Partners L.P.Limited Partnership Units BBU	FY2025	$27.5B	$387.0M	1.4%	$2.8B	23/100

Where Honeywell International, Inc. Ranks

Frequently Asked Questions

What is Honeywell International, Inc.'s annual revenue?

Honeywell International, Inc. (HON) reported $37.4B in total revenue for fiscal year 2025. This represents a 7.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Honeywell International, Inc.'s revenue growing?

Honeywell International, Inc. (HON) revenue grew by 7.8% year-over-year, from $34.7B to $37.4B in fiscal year 2025.

Is Honeywell International, Inc. profitable?

Yes, Honeywell International, Inc. (HON) reported a net income of $4.7B in fiscal year 2025, with a net profit margin of 12.6%.

What is Honeywell International, Inc.'s EBITDA?

Honeywell International, Inc. (HON) had EBITDA of $9.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Honeywell International, Inc. have?

As of fiscal year 2025, Honeywell International, Inc. (HON) had $12.5B in cash and equivalents against $27.1B in long-term debt.

What is Honeywell International, Inc.'s gross margin?

Honeywell International, Inc. (HON) had a gross margin of 36.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Honeywell International, Inc.'s operating margin?

Honeywell International, Inc. (HON) had an operating margin of 21.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Honeywell International, Inc.'s net profit margin?

Honeywell International, Inc. (HON) had a net profit margin of 12.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Honeywell International, Inc. pay dividends?

Yes, Honeywell International, Inc. (HON) paid $4.58 per share in dividends during fiscal year 2025.

What is Honeywell International, Inc.'s return on equity (ROE)?

Honeywell International, Inc. (HON) has a return on equity of 34.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Honeywell International, Inc.'s free cash flow?

Honeywell International, Inc. (HON) generated $5.4B in free cash flow during fiscal year 2025. This represents a 3.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Honeywell International, Inc.'s operating cash flow?

Honeywell International, Inc. (HON) generated $6.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Honeywell International, Inc.'s total assets?

Honeywell International, Inc. (HON) had $73.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Honeywell International, Inc.'s capital expenditures?

Honeywell International, Inc. (HON) invested $986.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Honeywell International, Inc. spend on research and development?

Honeywell International, Inc. (HON) invested $1.8B in research and development during fiscal year 2025.

Does Honeywell International, Inc. buy back shares?

Yes, Honeywell International, Inc. (HON) spent $3.8B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Honeywell International, Inc. have outstanding?

Honeywell International, Inc. (HON) had 636M shares outstanding as of fiscal year 2025.

What is Honeywell International, Inc.'s current ratio?

Honeywell International, Inc. (HON) had a current ratio of 1.30 as of fiscal year 2025, which is considered adequate.

What is Honeywell International, Inc.'s debt-to-equity ratio?

Honeywell International, Inc. (HON) had a debt-to-equity ratio of 1.95 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Honeywell International, Inc.'s return on assets (ROA)?

Honeywell International, Inc. (HON) had a return on assets of 6.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Honeywell International, Inc.'s P/E ratio?

Honeywell International, Inc. (HON) trades at 8.0x earnings, its market capitalization divided by net income of $8.2B net income, trailing 12 months to June 30, 2026. The market capitalization is $65.7B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Honeywell International, Inc.'s price-to-sales ratio?

Honeywell International, Inc. (HON) trades at 1.7x sales, its market capitalization divided by revenue of $38.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $65.7B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Honeywell International, Inc.'s Altman Z-Score?

Honeywell International, Inc. (HON) has an Altman Z-Score of 2.61, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Honeywell International, Inc.'s Piotroski F-Score?

Honeywell International, Inc. (HON) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Honeywell International, Inc.'s earnings high quality?

Honeywell International, Inc. (HON) has an earnings quality ratio of 1.36x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Honeywell International, Inc. cover its interest payments?

Honeywell International, Inc. (HON) has an interest coverage ratio of 6.05x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Honeywell International, Inc.?

Honeywell International, Inc. (HON) scores 63 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.